INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $277,181 | -6.7% | 8,766 | +20.3% | 0.01% | 0.0% |
| Q2 2023 | $297,123 | +22.1% | 7,286 | +11.6% | 0.01% | +10.0% |
| Q1 2023 | $243,410 | -0.2% | 6,531 | -4.0% | 0.01% | 0.0% |
| Q4 2022 | $244,020 | -26.1% | 6,801 | +15.0% | 0.01% | -33.3% |
| Q3 2022 | $330,000 | +13.0% | 5,912 | +4.5% | 0.02% | +15.4% |
| Q2 2022 | $292,000 | -25.3% | 5,656 | +5.1% | 0.01% | -7.1% |
| Q1 2022 | $391,000 | -38.5% | 5,380 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $636,000 | -11.9% | 5,380 | 0.0% | 0.02% | -19.2% |
| Q3 2021 | $722,000 | -11.0% | 5,380 | +7.4% | 0.03% | -10.3% |
| Q2 2021 | $811,000 | +126.5% | 5,009 | +12.3% | 0.03% | +107.1% |
| Q1 2021 | $358,000 | +54.3% | 4,462 | +4.5% | 0.01% | +27.3% |
| Q4 2020 | $232,000 | +172.9% | 4,270 | 0.0% | 0.01% | +175.0% |
| Q3 2020 | $85,000 | +4.9% | 4,270 | +10.3% | 0.00% | 0.0% |
| Q2 2020 | $81,000 | +118.9% | 3,872 | +27.1% | 0.00% | +100.0% |
| Q1 2020 | $37,000 | -17.8% | 3,046 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $45,000 | +9.8% | 3,046 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $41,000 | -2.4% | 3,046 | +18.0% | 0.00% | 0.0% |
| Q2 2019 | $42,000 | -4.5% | 2,581 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $44,000 | +25.7% | 2,581 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $35,000 | -52.7% | 2,581 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $74,000 | +4.2% | 2,581 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $71,000 | +173.1% | 2,581 | +107.3% | 0.00% | +200.0% |
| Q1 2018 | $26,000 | +8.3% | 1,245 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $24,000 | -7.7% | 1,245 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $26,000 | +30.0% | 1,245 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $20,000 | +150.0% | 1,245 | +128.9% | 0.00% | – |
| Q1 2017 | $8,000 | – | 544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |